Excerpt: Marijuana's primary psychoactive compound, Δ9-tetrahydrocannabinol (THC), drives persistent epigenetic changes that undermine neuroplasticity and reward system integrity, with cannabidiol (CBD) offering limited mitigation upon repeated exposure. These modifications, observed across preclinical and human studies, heighten risks for addiction, cognitive impairment, and intergenerational effects, particularly in vulnerable populations like adolescents.